Main competitors
Add to a list
Revenues ($) (Y-1) Net margin (Y-1) Operating Margin (Y-1) ROE (Y-1) ROA (Y-1) Leverage (Debt/EBITDA) (Y-1)
23.18B +13.45%+17.19%+14.03%+7.61%1.35x
3.09B +18.36%+21.67%+10.20%+9.89%-3.42x
1.38B +7.67%+3.05%+6.92%+5.15%-0.95x
264M -9.56%-10.45%-10.96%-4.74%4.35x
345M +14.17%+11.00%+6.89%+4.08%2.85x
1.7B +5.73% - +6.02%+3.55% -
206M +16.36%+18.84%+14.77%+12.61% -
608M +0.22%+20.59% - - -
1.09B +0.18%+24.61%+874.51% - -0.27x
257M +27.46%+30.65%+13.23%+9.94% -
590M - +5.52%+4.85%+3.16% -
529M +14.77%+5.31%+5.40%+2.55%-2.56x
116M -38.63%-30.91%-84.68% - 0.02x
3.69M - -659.58%-21.93% - 2.36x
573M +3.21%+6.54%+2.64%+1.43%5.16x
73.62M +16.96%+18.54%+5.47%+2.91% -
Average 2.13B +6.45% -34.49% +56.49% +4.85% 0.89x
Weighted average by Cap. 15.82B +11.68% +9.43% +19.70% +6.86% 0.88x
Specialty & Advanced Pharmaceuticals
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW